Healio3d
44% of patients with acute exacerbations of COPD have hypogammaglobulinemia
Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...
The Hospitalist1d
Gabapentinoid Use Associated with Increased Risk of Severe Exacerbations in Patientswith COPD
Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...
Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Daily7d
Inhaled Therapy with Ensifentrine Significantly may Reduce COPD Exacerbations, unravels research
A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.
Monthly Prescribing Reference9d
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Researchers found that the risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is vs DPP-4is and among those treated with GLP-1 RAs vs DPP-4is. HealthDay News ...
clinicaladvisor.com10d
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors. HealthDay News — For patients with type 2 diabetes (T2D) and chronic ...